Trade Development Authority of Pakistan (TDAP) has set $500 million pharmaceutical export target for next five years and has asked the stakeholders to develop “Pharma Vision 2013” to achieve the target.
“Pakistan Pharmaceutical Manufacturers Association (PPMA) should develop a comprehensive strategy paper as ‘Pharma Vision 2013’ so that the government and private sector have a clear roadmap on how to achieve this quantum leap” said Tariq Ikram, Chief Executive TDAP in a meeting with the Secretary TDAP, Naved Arif, Director General (Planning), Usman Hasan, and representatives of PPMA.
The meeting reviewed the export performance and noted with satisfaction the growth of 223 percent in export of pharma products from $32 million in 1998–99 to $102 million in 2006–07.
Major export destinations were Afghanistan, Sri Lanka, Philippines, Nigeria, Singapore, UAE, Sudan, Netherlands, Saudi Arabia, US, France and Germany.
It was also noted that each year since 1998–99 exports have progressively grown and major manufacturing companies were registering their products abroad and undertaking structured marketing efforts.
TDAP Chief emphasised that even the target of $1 billion was achievable since the local pharma industry successfully competes with multi-national corporations in Pakistan so they can compete with them abroad as well.
The growth of 223 percent in last 8 years shows that our export product quality and packing is acceptable and of international level.
Cost of production in Pakistan was lower and our industry was rapidly adopting world class GMP levels supported by the Ministry of Health and Government of Pakistan overall.